Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs
- 1 February 2011
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 72 (2), 184-193
- https://doi.org/10.2460/ajvr.72.2.184
Abstract
Objective—To assess efficacy and tolerability of robenacoxib for control of pain and inflammation in dogs undergoing orthopedic surgery. Animals—140 client-owned dogs. Procedures—A multicenter, prospective, randomized, blinded field trial was conducted to compare robenacoxib (97 dogs) and meloxicam (43 dogs). After randomization, each dog received an initial dose (robenacoxib, 2 mg/kg; meloxicam, 0.2 mg/kg) via SC injection before surgery and daily doses (robenacoxib, 1 to 2 mg/kg; meloxicam, 0.1 mg/kg) administered orally for up to 15 days after surgery. Efficacy was assessed by veterinarians and owners via numeric rating scales and visual analogue scales. Safety was assessed on the basis of reported adverse events, clinical signs, results of hematologic and biochemical analyses, and buccal mucosa bleeding times. Results—Treatment groups were balanced with respect to baseline and demographic data. Both treatments provided similar adequate pain control, as assessed with a modified Glasgow pain scale as the primary end point and supported by secondary end points in evaluations conducted by veterinarians and owners. For the primary end point, the ratio of the reciprocal of the scores for robenacoxib to meloxicam was 1.16 (95% confidence interval, 0.98 to 1.37). No dogs required rescue analgesia. Both treatments were associated with only minor adverse events, which were not necessarily related to the administered treatments and did not affect mucosal bleeding times. Conclusions and Clinical Relevance—Robenacoxib provided efficacy and tolerability similar to those of meloxicam for the management of perioperative pain and inflammation in dogs undergoing orthopedic surgery.Keywords
This publication has 25 references indexed in Scilit:
- In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: A comparative studyResearch in Veterinary Science, 2010
- Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dogJournal of Veterinary Pharmacology and Therapeutics, 2010
- Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2Journal of Veterinary Pharmacology and Therapeutics, 2009
- Efficacy and cost-effectiveness of transdermal fentanyl patches for the relief of post-operative pain in dogs after anterior cruciate ligament and pelvic limb repairVeterinary Anaesthesia and Analgesia, 2007
- Evaluation of epidural administration of morphine or morphine and bupivacaine for postoperative analgesia after premedication with an opioid analgesic and orthopedic surgery in dogsJournal of the American Veterinary Medical Association, 2006
- The effects of preoperative extradural bupivacaine and morphine on the stress response in dogs undergoing femoro-tibial joint surgeryVeterinary Anaesthesia and Analgesia, 2006
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Effects of meloxicam on renal function in dogs with hypotension during anaesthesiaVeterinary Anaesthesia and Analgesia, 2006
- Application of a scaling model to establish and validate an interval level pain scale for assessment of acute pain in dogsAmerican Journal of Veterinary Research, 2005
- A comparison of the postoperative analgesic and sedative effects of flimixin and pap aver etum in the dogJournal of Small Animal Practice, 1991